ࡱ> sur'` Rm)bjbjZrr V V V V V V V j 2228jD$j 'QPPPPPPP$RhaUBP9V W"WWPV V PWrV V PWPj~I\V V VO pi,2K26PLP0'Q LJVVdVO,VV O> ,L$pPPcX'QWWWWj j j $j j j j j j V V V V V V  Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.q\qge兡N gPlQSShandong Xinhua Pharmaceutical Company Limited(a joint stock company established in the People s Republic of China with limited liability)(Stock Code: 0719)ANNOUNCEMENTDISCLOSEABLE AND CONNECTED TRANSACTIONIN RELATION TO THE XINCAT PHARMACEUTICAL ACQUISITION Reference is made to the announcement (the Announcement) of Shandong Xinhua Pharmaceutical Company Limited (the Company) dated 29 January 2014 in relation the Xincat Pharmaceutical Acquisition. Capitalised terms not defined herein bear the same meanings as those defined in the Announcement. Subsequent to the Announcement, application has been made to, and approval has been obtained from, the Stock Exchange for the adoption of an alternative test (the Alternative Percentage Ratio) pursuant to Rule 14.20 of the Listing Rules in respect of the Xincat Pharmaceutical Acquisition. As the applicable percentage ratios pursuant to Rule 14.07 and the Alternative Percentage Ratio in respect of the Xincat Pharmaceutical Acquisition exceed 5% but are below 25%, the Xincat Pharmaceutical Acquisition constitutes a discloseable transaction of the Company under Chapter 14 of the Listing Rules.As disclosed in the Announcement, the Xincat Pharmaceutical Acquisition also constitutes a connected transaction under Chapter 14A of the Listing Rules.In respect of the two waiver applications made by the Company to the Stock Exchange as disclosed in the Announcement, approvals have been obtained and the following waivers have been granted to the Company from strict compliance with (1) Rules 14.62, 14A.56(8) and paragraph 29(2) of Appendix 1B under Rules 14.66(2) and 14A.59(3) of the Listing Rules; and (2) Rules 14.34 and 14A.47 of the Listing Rules.A circular containing, inter alia, (i) further details of the Xincat Pharmaceutical Acquisition; (ii) a letter of advice from Cinda International to the Independent Board Committee and the Independent Shareholders; and (iii) the recommendation of the Independent Board Committee to the Independent Shareholders in respect of the Xincat Pharmaceutical Acquisition, will be dispatched to the Shareholders as soon as possible.By Order of the Board Shandong Xinhua Pharmaceutical Company Limited Zhang Daiming Chairman18 -Z [ q r t  x 0 2 V X ξξξΤn_OE4!h[!CJKHPJaJnHo(tHh[!CJKHaJh[!6CJKHPJ]aJo(h[!6CJKHPJ]aJ*h[!B*CJOJPJQJ^JaJo(phh[!5KHPJ\aJo(#h[!6KHPJ]aJnHo(tH3jh[!5KHPJU\aJmHnHo(tHuh[!6CJKHPJ]aJo(h[!6CJKHPJ]aJh[!6CJKH]aJo('h[!6CJKHPJ]aJnHo(tHq s t u v  x 2 X Z t   AB45$1$7$8$H$a$gdq $7$8$G$H$a$$7$8$G$H$`a$$a$ $7$8$H$a$ $7$8$H$a$P)l)X Z    > ? C D P S V ǯsfZKZ?hCJKHPJaJh6+5CJKHPJ\aJh6+CJKHPJaJh6+CJKHPJaJo(he\h:5CJKHPJaJh{GCJKHPJaJh:CJKHPJaJhe\hCJKHPJaJ h[!o(.hBhh[!5CJKH\aJmH nHsH tH(h['5CJKH\aJmH nHsH tH.hBhh['5CJKH\aJmH nHsH tHh[!PJnHo(tH 23>?@ACYǽdzwwk[kwKhh['CJKHPJaJo(hTehTe5CJKHPJaJh>CJKHPJaJhZ-qCJKHPJaJh['CJKHPJaJh6+CJKHPJaJh[!CJKHPJaJh:CJKHPJaJh:CJPJaJh,1CJPJaJh4*h:CJPJaJhCJKHPJaJhe\hCJKHPJaJhe\hCJKHPJaJo(Ydef1<ͱweSeD4Dhh'0CJKHPJaJo(hh'0CJKHPJaJ"h,1CJKHaJmH nHsH tH"hG;UCJKHaJmH nHsH tHhG;UCJKHPJaJhh>CJKHPJaJhh>CJKHPJaJo(hhZ-qCJKHPJaJhhZ-qCJKHPJaJo(h>CJKHPJaJhZ-qCJKHPJaJh6+CJKHPJaJh['CJKHPJaJhh['CJKHPJaJ$%345#DžygU@1hfhICJKHPJaJ(hfhICJKHaJmH nHsH tH"hICJKHaJmH nHsH tH"hkXCJKHaJmH nHsH tHh]CJKHPJaJhe\CJKHPJaJh,1CJKHPJaJh>CJKHPJaJhG;UCJKHPJaJ"hG;UCJKHaJmH nHsH tHhkXCJKHPJaJh'0CJKHPJaJh'0h'0CJKHPJaJ"h'0CJKHaJmH nHsH tH,-stu͸ueVeGVeVGh]5CJKHPJ\aJh[!5CJKHPJ\aJh[!5CJKHPJ\aJo(h[!CJKHPJaJh[!CJKHPJaJo(hfh[!CJKHPJaJh]CJKHPJaJhfhe\CJKHPJaJ(hfhe\CJKHaJmH nHsH tH"hkXCJKHaJmH nHsH tH(hfhICJKHaJmH nHsH tHhICJKHPJaJ5tu((U(V(k((( $$G$Ifa$$G$a$ $7$8$G$H$a$$,7$8$G$H$a$$7$8$G$H$a$7$8$G$H$$R7$8$G$H$^`Ra$gdf 1$7$8$H$gdkX$1$7$8$H$a$gdf(( ( (((((l(۽̬}l[OD6h[!CJPJaJnHtHh[!CJPJaJo(h[!CJKHPJaJ!hfgCJKHPJaJnHo(tH!h9CJKHPJaJnHo(tHUh[!CJKHPJaJo(h)#JCJKHPJaJnHtHhfCJKHPJaJnHtH!h[!CJKHPJaJnHo(tHh]6CJKHPJ]aJh[!6CJKHPJ]aJh[!6CJKHPJ]aJo('h[!5CJKHPJ\aJnHo(tHFebruary 2014, Zibo, PRCAs at the date of this announcement, the Board comprises: Executive Directors:Mr. Zhang Daiming (Chairman)Mr. Du DepingMr. Zhao SongguoIndependent Non-executive Directors:Mr. Zhu BaoquanMr. Bai HuiliangMr. Kwong Chi Kit, VictorNon-executive Directors: Mr. Ren Fulong Mr. Xu Lie Mr. Zhao Bin PAGE 1l(m(o(|(((((((')1)7)=)>)L)O)P)Q)S)T)V)W)Y)Z)\)])^)_)e)f)g)h)i)j)k)l)m)ÿh[!CJPJnHtHh[!0Jo(h"0JmHnHu h[!0Jjh[!0JUh[!h[!6CJ]o(h>=Kjh>=KUh[!CJaJo(h[!CJPJaJnHtHh[!CJPJaJnHo(tH%((((()) )#)3)?)L)M)N)Gkd$$If0.w 64 a $$G$Ifa$N)O)P)R)S)U)V)X)Y)[)\)])^)i)j)k)l)m)$`a$$a$$4$a$Gkdc$$If0.w 64 a6 00&P P. A!"##$% nu*l?xK-PNG  IHDRryJzgAMA pHYsLLXtcPLTE#$ 84*&'"51;7.*?;2-2./+40)%(#,(=9950,+'=83.627383B>B?A=C?@=QNUQNJFBJFXU\Y^[DAZWIF]ZOKHDWSQMMJKHSOD@YUVSLISPFCYV[W^ZROLHOLWTb_`\a^b^`]iftrfc}pn|ymjxupmvtywc`li~{}{wt}{rogdvsda~{xuebnkkgkholtqheqnpnspzw{x~}ƵG'IDATx}|yNg˲$Dz6d[r^ 8&!iP*`Ԙ˒lbh^ZQ@!M#'MI4mt/kvӦMO$nwvgyfgwgt7<3(Z8˱!}t%O_dKU}*meDW܇lL7{]+>IcMC|l4IzO̚*Irìi.! gKz8T*%,佫X ˏ<&K$]vUtɑ,VEzIyH.#Ϛ!tifPIѳf$]Nfx$]F䜳fX$]>.fpHl]Κatg&o#K>k.8ietgƾUFI9|֌4&(D2I$ʴ[K\Co~$]YgȎ*FC$A#eY/c#"OFj+ <#۠1kZǮWM?f5$=Y!R+K.>k*qبPެM`$oY _&I1k̊/ 6/~"G̚J]Y͠E-%B$cJME.s`SϒrĬ9ö"^}2JOfdGʶ*Fwt%YSYw-V21 1y oU2l"lJK=G5ڠ}>i&{1kF%03%)Iy?|Tjzώ|vK{Áw돳L&)sI:i<";ZKܔ{< 5$1FT=twLW|^2? 6{) _%R;I1fI~3Dv F)+I3kFf4b[jNv)I3k* 5lc557{"bcfMsWz_&[lJ@E"̚ K,iM%]r̬IUlr̙p +颐cfM ߽٨Ɇ7t1QQai˿.9fdUll)] @5mB*ëN* tQ~͗26w_pS Iw5km{ޕCL3u B]!G͚,6gt9fִ: qsѪ”%(Y(iD TW#fMA$)/pY AA8z=CfMQ`J/{]MYS:Naq&(D08J;0tCfMQ@ "4\ҝfȶsidz?t;"G͚DtGaJJrܬs"paL IE5yBRlLB ͚.BSl鱊1;K;O9kz~"bsz s[QG#gMe~6iDjcLI!GΚ~ؤS\m%]Κ~$N#)}BܬQ`]j]|sa\Q#y0Y >/ <ʔ>&FzQœt/8EXlFt<ʔ_k=+= 071ox ɕpAqQj] *>~.6Q,tzM (Q_6\#frRLQB]uIRvpzM eۣ|mwJ63;VVX RԣLQ']iѧ3O޵ˍznq(ybE>)ΉFIX88S:U ,U3sdθT`"NBBonaEBORVV+x2j ' s%NR08E=ƓGVhbf#i+zbiӪ8SR"DKnb5rSWMu;6rH[!V#3S0Ow.Bd.A#[̕`XPg #ȂE#/93fZeɌ\S{<03Ol#4 2)J{d<=`[Sԗ ˀ\S%-x,-|@u=݅}55FJ77(\dcs'`}IIFKgnFmNڳw8B?Hz,s-ډ-}ֽ-V,a \954O|\*Kѹ\nW"ZO_^6MSa&y <07t|-s<7{<2*C6m,^YZ=@9Q(iE0b+ANlzQ~O9Q_\jVv^X !*y{F0DiR#ϲӓO5||@c|ȋA^Ɍ=t*"GIgPݙ-M> 9RP86uimڰJsp>/;|(|=i :\2noi@ Wߍ}kj qg@>a19i?K]~되>>7xlgߗ@g sh.~K|~ xs>"¹7U­Ůһ4vvg^i4so8xgkSdpG+'rmS}̈́ð)wh39jkku?ʒa@VfN6:%BwSTjc9u h5#p%k _=ANWvm)eͯlW+RuKw)]zYv})K-_%)kxb[nZ TVdxN~Uwjb;? bPVWȵ!|,<}qP ~9kZgL/g}lIV6z tNyPw\ܵ!1[gtwA[h%#N0y@d z|+C ŕ5G.Yn1<'`MMM7}dy(B#,yKg\7S;w²n r<0w :ҹ0)oux9֖~e⯖gs4[_Sۿ[ rf;G^8}EO{뢂G\Y/XId(Wp=Lh+ve7(so+}Gi'Mp_kk'KD74mфG-1 >cUƱe9 +5?r/:i@~D Gu݅fIZ`UEN 'D%=u\ 3A~ YoaEٷs7Dޠ_E8@-J1|s )rOAO.мE%!185<Ӧi_r`/qc/*!wR?̱+[=aǎ0{̱~}ee];Mf-nz1_W<o5O_cc>YF3>xפ@r.GΏcM]G}EuT)My+78ϻﵱ7Wa=U=_sYjr uK7xCuQ_?Yf n% ؜G-Y`n9 R9؆۳˔F„܀?mG^ {:Fߘ2C7CTk=\@pFk}j&'jv r5qC[:+@ުv߈MarCij BNԓ~P-w9j| 4E"G9 eljUc9!~sS̊PSFF:"YeSC\yHf GL2;6h3c&TiWyf|;tk$o59Yh{w{QȉJN,tΐH#\2*ّ$ʥ ~G0M}"'߇ǽ#FCx#;]vkr"']yVjMN\wn^ZǡWZ#Oo3w,J1G%EBOM_!X#ׯͦۡ"'rLQ5r})mx }M(%r3>QH}/yfN^܌ur"ȹOf5Z.\F|ߩch !~ kn*e#7vReUS8%!G~e`[pCheeAUsn+dz.~#GF3ܟ 9fu<' tW:H<:Kg I;N]:֜op?vԼ,Bkm܍VE8'w c$a_SPTVn58pi.7Ȋ|֜N)meX>wK*)07f^xz)G4w0oVjtP\RQ^so= PկMAwoIң_:û]ul#t0tHq}g:v.;'ѻ\^Vz9WʽRm5ݪ~yv N}Y!Pr&lj&(9f4@k|9!KE\oEqo*<#Z8kcu#QMe"w,:p/ė%"'W+S3'rN"Cr{\]^-P:~pOqL /r[+:@0#ֳ!9bb0,~[;|oB-l$rS't| !G4>ޱ ANg\RSVtDåZ-rTuif=˿1ȭ$K!O8f;`ŽsݦFvzozpWލ+++^=aG>@W2۱ή^=":۷{Eeu}sǂX>h#'Jg 3'U y>K ;rMyUQ v77- ?r*3arCޛ}u7^=n^n7]Vjz~T,PT|' %zo^ IL]" *^e6rg2OCy|l oPVmR rK?1f>B7pvk^77eT$r*gFE/AFj69iF= )N75u cy~iFƧ s|n14#kꑎ,EwA"^(m<x$|Drn=2P Wʻ Sp J<񉲋Jܔ3U=F/5>JtM"@4j|:@ !,rE/*քU5lώU}Mmy=wMu%{nA܇+ߒnzkݼhMBt#`+iyWw T?%EeM}'jӖb76f5`D<$Z $}7uQdk"%Z CrŃ⏤79#㦪5ǥDxOQEWaTnePu}?L(*hc^*R^QbEP/{ |%.#;f?d ?iKz $"l+is=x(J|kc.85`(hJ(l_sY^c%NQHiЕĶXĻCY#+=raDF+CBb~X?ĉx >< ptAwEԜӇjZRI7f. qmZ8CbeA!x%%p/ =K5Q$ݴkG\#^UC6I7rfU;o6n^6 _)ꊝeml 1vi,w.x4̉J.8IoIýlw'kmb JSQ>c釐<7 HһGGZSKG{WD{s{i\^6 <$=ߍq3htcS<W} 4|lMbϛvU*=8N1g,3{6]"Iqԋ[$|V'[g 4rgrH:X^6rWoqH8*n+t0E}hW f%&PQ U籤CE<L%.Iq`JmDCB6666666666666666666666666666666666666666666666666hH666666666666666666666666666666666666666666666666666666666666666666D@D cke1$ CJKH_HaJmH nHsH tHh@h h 1&$$s@&^`sa$5B*CJOJQJ\^JphT@T h 2$$7$8$@&H$a$5CJ$KHOJQJ\aJ$H@H h 3$$ & F@&G$a$5\nHtHB@B h 4$$@&G$a$5\nHtH^@^ h 5"$$7$8$@&G$H$^a$5KHPJ\aJnHtH^@^ h 6!$$ & F7$8$@&G$H$a$5KHPJ\aJnHtH^@^ h 7!$$ & F7$8$@&G$H$a$5KHPJ\aJnHtH$A@$ ؞k=W[SOFi@F 0nfhINhlNC`|V|2sVPD,w6 4X *֊15Vou;$ZScVI4+XPTX ]r-J^s$bΩzk&iVlz+gl~oLu9sBu$]| hh^h`5o(. ^` 0 ^` . ^` .`  ` ^` ` 0@  @ ^@ ` .   ^ ` . ^` 0 ^` .hh^h`5o(. ^` 0 ^` . ^` .`  ` ^` ` 0@  @ ^@ ` .   ^ ` . ^` 0 ^` .^`o(.D D^D` 0$  $ ^$ ` .   ^ ` .   ^ ` 0 ^` . ^` . ^` 0d d^d` .^`o(.( (^(` 0 ^` . ^` .   ^ ` 0   ^ ` . ^` .h h^h` 0H H^H` . ^` PJo(. ^` 0 ^` . ^` .`  ` ^` ` 0@  @ ^@ ` .   ^ ` . ^` 0 ^` .^`PJo(.D D^D` 0$  $ ^$ ` .   ^ ` .   ^ ` 0 ^` . ^` . ^` 0d d^d` .HH^H`o(() ^` 0 ^` .`  ` ^` ` .@  @ ^@ ` 0   ^ ` . ^` . ^` 0 ^` .^`o(.   ^ ` 0 ^` . ^` . ^` 0   ^ ` .l  l ^l ` .L L^L` 0, ,^,` .h<^<`o(hH()h  ^ `hH.h L^`LhH.h  ^ `hH.h |^|`hH.h LL^L`LhH.h ^`hH.h ^`hH.h L^`LhH.T0T^T`0o(()D D^D` 0$  $ ^$ ` .   ^ ` .   ^ ` 0 ^` . ^` . ^` 0d d^d` . ^` o(. ^` 0 ^` . ^` .`  ` ^` ` 0@  @ ^@ ` .   ^ ` . ^` 0 ^` .hh^h`PJo(. ^` 0 ^` . ^` .`  ` ^` ` 0@  @ ^@ ` .   ^ ` . ^` 0 ^` .,,^,`o(. ^` 0d  d ^d ` .D  D ^D ` .$ $^$` 0 ^` . ^` . ^` 0 ^` .hh^h`o(. ^` 0 ^` . ^` .`  ` ^` ` 0@  @ ^@ ` .   ^ ` . ^` 0 ^` .^`o(() ^` 0 ^` .   ^ ` .|  | ^| ` 0\ \^\` .< <^<` . ^` 0 ^` .hh^h`o(. ^` 0 ^` . ^` .`  ` ^` ` 0@  @ ^@ ` .   ^ ` . ^` 0 ^` .::^:`o(. ^` 0 ^` . ^` .`  ` ^` ` 0@  @ ^@ ` .   ^ ` . ^` 0 ^` .^`o(.404^4`0o(()$  $ ^$ ` .   ^ ` .   ^ ` 0 ^` . ^` . ^` 0d d^d` .d0^`0PJo(. ^` 0 ^` .`  ` ^` ` .@  @ ^@ ` 0   ^ ` . ^` . ^` 0 ^` .hh^h`o(. ^` 0 ^` . ^` .`  ` ^` ` 0@  @ ^@ ` .   ^ ` . ^` 0 ^` .hh^h`o(.HH^H`o(.((^(`o(. ^` .`  ` ^` ` 0@  @ ^@ ` .   ^ ` . ^` 0 ^` .HH^H`o(. ^` 0 ^` .`  ` ^` ` .@  @ ^@ ` 0   ^ ` . ^` . ^` 0 ^` .|9scVI$b~o+[?~6 -J^9s; 9s; 9s(; 9s9sXNhlX *]l]|+glXPTou;9sVC&i15nŀK        0!        jb։        fL        ҅        fRi        ;j                |        Kz        NW        &nG        Zn        B$        X"        X        &DM        |6.       l,        ",p        [ >$      k         @ @@ @'&Teq [!K?(6+'0jE)#J(7J>=KG;UkXe\fBhZ-q9D[M,1Nfg{Gs;RI":['>6'(p]%E  } ~ o @@w4vvu @@@ @@@P@UnknownGz Times New Roman5Symbol3& z Arial;[SOSimSunKM  DFKai-SBPMingLiUC .PMingLiUe0}fԚO Times-BoldPMingLiU 1hX"GZ"G"G  !?!),.:;?]}    " % & ' 2 t%00 0 000000013468:<>@BDOPQRTUVWZ\^ \]d([{  5 0 0 00000579;=?ACY[][d B JqXZ $PjE2~The Stock Exchange of Hong Kong Limited takes no responsibility for the contents of this announcement, makes no representation CARRIECHENGhggSfd                 Oh+'0(4HT`p    The Stock Exchange of Hong Kong Limited takes no responsibility for the contents of this announcement, makes no representation CARRIECHENGNormal3Microsoft Office Word@F#@|Y,@Xi,@qi, ՜.+,0 X`t|  Charltons '   !"#$%&'()*+,-/012345789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`acdefghiklmnopqtRoot Entry Fpci,vData .1Table6WWordDocumentZSummaryInformation(bDocumentSummaryInformation8jCompObjm  FMicrosoft Office Word ĵ MSWordDocWord.Document.89q